These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 7678867)

  • 21. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
    Gruber A; Larsson R; Nygren P; Björkholm M; Peterson C
    Leukemia; 1994 Jun; 8(6):985-9. PubMed ID: 7911547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies.
    Merlin JL; Guerci A; Marchal S; Missoum N; Ramacci C; Humbert JC; Tsuruo T; Guerci O
    Blood; 1994 Jul; 84(1):262-9. PubMed ID: 7912556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro.
    Pourtier-Manzanedo A; Boesch D; Loor F
    Anticancer Drugs; 1991 Jun; 2(3):279-83. PubMed ID: 1724925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
    Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
    Van de Vrie W; Gheuens EE; Durante NM; De Bruijn EA; Marquet RL; Van Oosterom AT; Eggermont AM
    J Cancer Res Clin Oncol; 1993; 119(10):609-14. PubMed ID: 8101524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
    Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
    J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I; Doherty G; Moran E; Clynes M
    Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.
    Ikegawa T; Ohtani H; Koyabu N; Juichi M; Iwase Y; Ito C; Furukawa H; Naito M; Tsuruo T; Sawada Y
    Cancer Lett; 2002 Mar; 177(1):89-93. PubMed ID: 11809535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
    Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Watanabe T; Tsuge H; Koyama T; Oh-hara T; Tsuruo T
    Int J Cancer; 1996 Jul; 67(3):435-40. PubMed ID: 8707421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line.
    Takeda Y; Nishio K; Niitani H; Saijo N
    Int J Cancer; 1994 Apr; 57(2):229-39. PubMed ID: 7908894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.